Pharmacovigilance

Our capabilities include:

• Adverse event collection and case management
• Signal management and risk assessment
• Aggregate safety reporting
• Post-marketing pharmacovigilance support
• In EU, full supply of pharmacovigilance services incl. QPPV

Our approach

Pharmacovigilance at Argenta is fully integrated with clinical development and regulatory strategy. This ensures:

• Continuous safety monitoring across the lifecycle
• Efficient, scalable processes aligned with global regulations
• Rapid identification and evaluation of safety signals

Your advantage

• Full compliance with EU and UK pharmacovigilance requirements in clinical studies
• Assurance of market access
• Protection of product value
• Confidence in long-term product safety and performance